Calidi Biotherapeutics posts presentation on new wholly owned subsidiary Redtail Biopharma

Calidi Biotherapeutics, Inc.

Presentation made available August 22, 2024 on company website.
Redtail Biopharma, Inc. is a new wholly owned subsidiary of Calidi Biotherapeutics.
No financial terms or strategic details disclosed in the 8-K or presentation excerpt.

item 7.01 item 9.01

Calidi Biotherapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-24-033579

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.